Aceon and Hyperkalemia - a phase IV clinical study of FDA data

Summary:

Hyperkalemia is reported as a side effect among people who take Aceon (perindopril erbumine), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Crestor, and have Cardiac failure.

The phase IV clinical study analyzes which people have Hyperkalemia when taking Aceon. It is created by eHealthMe based on reports of 1,743 people who have side effects when taking Aceon from the FDA, and is updated regularly.

What is Aceon?

Aceon has active ingredients of perindopril erbumine. It is often used in high blood pressure. eHealthMe is studying from 1,785 Aceon users. Check the latest studies of Aceon.

What is Hyperkalemia?

Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,957 drugs and 2,937 conditions by eHealthMe. Check the latest studies of Hyperkalemia.

On Jul, 10, 2026

1,743 people reported to have side effects when taking Aceon.
Among them, 67 people (3.84%) have Hyperkalemia.

Among these 67 people:

How long have people been on Aceon when they have Hyperkalemia? *

What is the gender of people who have Hyperkalemia when taking Aceon? *

female: 46.15 %
male: 53.85 %

What is the age of people who have Hyperkalemia when taking Aceon? *

What are other drugs people take besides Aceon? *

What are other side effects people have besides Hyperkalemia? *

Acute Kidney Failure: 32 people, 47.76%
Hypotension (abnormally low blood pressure): 13 people, 19.40%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 10 people, 14.93%
Nausea (feeling of having an urge to vomit): 9 people, 13.43%
Dyspnea (difficult or laboured breathing): 8 people, 11.94%
Weakness: 8 people, 11.94%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 10.45%
Dehydration (dryness resulting from the removal of water): 7 people, 10.45%
Bradycardia (abnormally slow heart action): 7 people, 10.45%
Lactic Acidosis (low ph in body tissues): 6 people, 8.96%

What are the existing conditions these people have? *

Cardiac Failure: 8 people, 11.94%
Type 2 Diabetes: 5 people, 7.46%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 4.48%
Left Ventricular Dysfunction: 2 people, 2.99%
Cardiac Failure Congestive: 2 people, 2.99%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 2.99%
Diabetes: 2 people, 2.99%
Essential Hypertension (primary hypertension): 2 people, 2.99%
Hypokalemia (low potassium): 2 people, 2.99%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 1 person, 1.49%

* Approximation only. Some reports may have incomplete information.

Do you take Aceon and have Hyperkalemia?

- Check whether Hyperkalemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aceon:

Aceon (1,785 reports)

Hyperkalemia treatments and more:

Hyperkalemia (78,084 reports)

Browse all side effects of Aceon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperkalemia:

Hyperkalemia (1,957 drugs)

Browse all the conditions that are associated with Hyperkalemia:

Hyperkalemia (2,937 conditions)

Related publications that referenced our studies

Krishnan K, Krishnasamy K, "Evaluation of anaphylactic reaction as an adverse event for perindopril erbumine tablets", International Current Pharmaceutical Journal, 2014 Mar .
Krishnan K, Krishnasamy K, "Evaluation of anaphylactic reaction as an adverse event for perindopril erbumine tablets", International Current Pharmaceutical Journal, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on perindopril erbumine (the active ingredients of Aceon) and Aceon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.